Farallon Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

$21.4 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.0 - $329.83 $0 - $172 Million	-522,000 Closed	0 $0
Q4 2023 May 15, 2024	BUY	$161.01 - $317.85 $84 Million - $166 Million	522,000 New	522,000 $165 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $362,252 - $479,776	2,200 New	2,200 $371,000
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $14.9 Million - $18.4 Million	-77,800 Reduced 97.25%	2,200 $432,000
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $2.48 Million - $5.55 Million	-20,000 Reduced 20.0%	80,000 $18 Million

Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $23.5 Million - $35.8 Million	-250,000 Reduced 71.43%	100,000 $12.7 Million
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $19.8 Million - $26.5 Million	-200,000 Reduced 36.36%	350,000 $44.4 Million
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $16.6 Million - $23.9 Million	-150,000 Reduced 21.43%	550,000 $72.1 Million
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $7.08 Million - $8.81 Million	70,000 Added 11.11%	700,000 $85.6 Million
Q2 2021 Aug 13, 2021	SELL	$107.45 - $135.95 $4.84 Million - $6.12 Million	-45,000 Reduced 6.67%	630,000 $71.8 Million
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $2.39 Million - $3.33 Million	-25,000 Reduced 3.57%	675,000 $81.2 Million
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $8.91 Million - $13.7 Million	125,000 Added 21.74%	700,000 $54.1 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $494,199 - $932,171	7,953 Added 1.4%	575,000 $64.1 Million
Q1 2020 May 15, 2020	SELL	$60.41 - $115.92 $1.99 Million - $3.82 Million	-32,953 Reduced 5.49%	567,047 $40.8 Million
Q4 2019 Feb 13, 2020	BUY	$11.44 - $123.99 $6.86 Million - $74.4 Million	600,000 New	600,000 $45.2 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

333K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account